This Tech Stock Has Printed Money for Patient Investors for 5 Years, and It's Still Cheap

Onto Innovation posted record full-year 2025 revenue of about $1.005 billion and guided Q2 2026 revenue to $320 million-$330 million, above prior expectations, while raising full-year 2026 growth outlook to more than 30%. The Dragonfly G5 advanced packaging tool has completed qualification and is set to ship first units in June 2026, while a >$240 million HBM purchase agreement through 2027 supports backlog visibility. Risks remain from customer concentration and competition from Applied Materials and KLA, but the article frames Onto as a key AI packaging beneficiary with additional upside to the $334 average price target.

Analysis

ONTO is becoming a leverage point on AI capex that is further out on the supply chain than the usual GPU names, which matters because inspection/metrology spend tends to rise when packaging complexity rises faster than wafer starts. The second-order effect is that every incremental dollar into chiplets and HBM can force a disproportionate pull-through into process-control tools, so ONTO can keep compounding even if headline semiconductor unit growth moderates. That said, this is also a concentration story: the same AI customer mix that is driving upside makes the revenue base more sensitive to a small number of procurement decisions and qualification slippage.

The market may still be underestimating how much of the next leg is already de-risked by qualification and contract coverage. A first-shipment event on a next-gen platform usually matters less for the announcement than for the conversion curve over the following 2-4 quarters, because tool acceptance, install timing, and follow-on order cadence can re-rate the whole backlog narrative. If AI packaging demand stays intact into 2H26, ONTO has a clean path to multiple expansion as margins step up; if the HBM cycle softens, the stock can de-rate quickly because investors are paying for visible growth, not cyclical optionality.

The contrarian read is that consensus is probably focused too much on the revenue line and not enough on competitive intensity. Large-cap peers can subsidize packaging R&D longer than the market expects, so ONTO’s moat is less about technology uniqueness and more about being the fastest-qualified solution at the right customer nodes. The right way to think about the stock is not as a pure AI winner, but as a high-beta tollbooth on advanced packaging spend with a narrower failure mode than GPU names and a sharper drawdown if one or two hyperscaler/HBM budgets roll over.

Key Decisions for Investors

• Go long ONTO on any post-rally consolidation or gap-fill toward the prior breakout zone; base case 3-6 month upside is driven by margin revision rather than revenue surprise, with downside capped only if 2H26 order conversion remains intact.
• Use a pair trade: long ONTO / short KLAC on a 2-4 month horizon if you want exposure to AI packaging without paying for broader semi-cycle beta; thesis is ONTO has cleaner direct leverage to HBM/2.5D mix, while KLAC is more exposed to normalization in other inspection buckets.
• Buy ONTO call spreads 3-6 months out rather than outright calls if you expect continued upside but want to limit multiple-compression risk after the next earnings print; target a 1:2 or better risk/reward into the next guidance update.
• For hedged portfolios, consider a small short AMAT against ONTO only if you believe competitive packaging share shifts will accelerate; this is a slower-burn trade and should be sized modestly because AMAT can absorb R&D pressure longer than the market expects.
• Set a hard risk trigger: if HBM/order commentary weakens for one quarter or qualification delays appear, trim quickly rather than averaging down; ONTO will likely trade on forward visibility, not trailing execution.